|
Life science and biotechnology is of great importance to China. The Chinese
government attaches much attention to the development of modern life sciences,
as we believe that biotechnology will help us to solve the most urgent
problems, such as population, food supply, health care and environment
protection.
I. Different Programs Initiated to Support Modern Life Science and Biotechnology
Since the seventh 5-year plan (1986-1990), the Chinese government has
been implementing a couple of programs that prioritize the development
of biotechnology. The programs cover a wide spectrum in basic research,
high-tech development as well as industrialization, which include Basic
Research Program, Hi-Tech Research and Development Program, Key S&T
Problem Solving Program, Key Science Infrastructure Program, Key Industrial
Pilot Program, as well as the establishment of Key Laboratories and Engineering
Centers, etc.
Science and education hold the key to a prosperous future. The funding
from government for R&D has been increasing continuously during the
past over 20 years. We have adopted preferential policies in venture capital
and taxation for the research institutes and high-tech companies. Many
R&D centers and bases on biotechnology have been set up and more and
more scientists with Ph.D. degree are returning home after receiving training
in western countries. There are more than 400 universities, research institutes
and companies and a total of over 20,000 scientists and researchers involved
in biotechnology. The number of research papers being published internationally
is increasing rapidly.
II.Industrialization of Biotechnology Emphasized
The Chinese government mainly plays three roles in the promotion science
and technology development. First of all, the government should strengthen
the support to basic research. It is the basis of any new knowledge and
methodology. Secondly, favorable policies and necessary conditions should
be created for technology innovation, transfer and industrialization.
They need a stable macro-economy, a healthy financing system, an educated
labor force, a competitive market environment, etc. Thirdly, innovation
system should be improved. Innovation relies no longer on companies or
institutes alone, but on integrated efforts from both sides. Obstacles
on cooperation and networking should be removed and close connection should
be set up through networking among universities, public organizations,
industrial companies and financial institutions.
In order to promote integration of science, technology and the economy,
following policies have been implemented in China:
(1). Setting up high-tech incubators for biotechnology
(2). Making favorable taxation policies for biotechnology development
(3). Supporting SME's in biotechnology field
(4). Encouraging venture capital investment and technology transfer
(5). Setting up specific zones for high technology development
(6). Recognizing intellectual properties as capital investment
With the efforts of the government, the scientific community and the industries,
we have made significant progress in biotechnology development.
a. The total sales of biotechnological products in China have increased
by 50 times during the past 10 years. In 1997, it was about 13 billion
RMB (USD 1.6 billion). In the year 2000, it reached more than 20 billion
( US$2.5 billion).
b. A total of 18 bio-pharmaceutical products have been commercialized,
including recombinant medicines and vaccines. 30 more are on the stage
of clinical trials.
c. Crop breeding techniques are generating huge economic value in China:
the yield of super hybrid rice is as high as 100kg/ha per day in rice
growing period.
d. China is one of the earliest countries to carry out gene therapy for
patients and Chinese scientists have found out several disease genes including
the neural deaf gene.
Furthermore, we have also made important progress in bio-pesticides,
disease diagnosis and treatment techniques. And we are reforming national
traditional bio-industry. Nowadays, biotechnology has shown its importance
for China's economy and social development.
III. Challenges to Biotechnology and Life Science in China
1. The Bio-safety issue
With the development of life science and bio-industry, the bio-safety
issue becomes inevitable. The development does provide us with superior
techniques in many fields. It also presents us with unprecedented issues,
such as bio-safety, intellectual property rights protection, etc. The
statistics suggested that there are more than 44 million hectares of transgenic
plants in the world. The transgenic technique has brought huge benefits
to many countries. However, governments, scientists and the general public
of the countries also face the challenge of bio-safety and bio-ethics
issues.
The Chinese government actively supports the research and development
in biotechnology and transgenic techniques. However, we have attached
great attention to bio-safety issue.
The following are our basic policies on bio-safety.
(1). Formulating laws and regulations on transgenic products
The Chinese government first passed "Bio-Engineering Safety Regulations"
in 1983. Currently, we are drafting National Law on Bio-Safety. This is
a joint effort among S&T, agricultural, food, medical sectors.
(2). Establishing scientific standards for evaluating long-term safety
issues
The Ministry of Science and Technology has set up a special program to
carry out further research on related bio-safety issue so as to evaluate
objectively the safety based on scientific criteria.
(3). Encouraging mass media and public involvement
The Chinese government makes the information accessible to the public.
People need to know not only the whole truth regarding the transgenic
products, but also its benefits to human being. We are doing our best
to ensure the profit of any new technology, while minimizing its potential
risk for human being and the environment.
2. The Issue of Intellectual Property Right Protection
Innovation is the power of knowledge-based economy. Protection of intellectual
property rights will stimulate and accelerate the technology transfer.
We have to keep a good balance between the free information exchange and
protection of inventors' interests. To take human genome project as an
example, China is a part of the consortium, and we insist that all of
the basic human DNA sequence information should be available to the public
and used freely. In the meantime, we agree to the patent protection of
advanced techniques and new products, especially in functional genomic.
China has been adopting the policy to protect the patents and intellectual
property rights. We have gradually established various laws and the regulations
regarding patents, trademarks and copyrights. The Chinese government formally
accepted the international consensus on patenting and intellectual property
right protection. We have been working hard to create an environment to
recognize patents and protect the interests of patent owners. As a result,
the number of patent applications in China has increased significantly
during the past few years.
IV. Promotion of International Cooperation and technology Transfer
1. Competition Leads to Innovation, Cooperation Leads to Prosperity
In today's global economy, scientific collaboration has become the main
stream of development. China has made a great progress in national economy
during the past over 20 years and we believe that international cooperation
will help us to achieve our goal. Up to date, the Chinese government has
established active scientific cooperation and exchange programs with 152
countries throughout the world. We have signed the agreements with 96
countries for research collaboration. The cooperation has different formats,
including the collaboration on joint investigation, basic research and
industrialization.
The Chinese government will continue to implement the open-door policy
and the economic reform. We will initiate some research programs for international
collaboration. The government has approved to set up a specific fund to
support International cooperation during the tenth 5-year plan.
2. Equal Partnership and Mutual Benefits as Key to Successful International
Scientific Cooperation
There is a common saying, "Everyone has its own advantages".
For scientific cooperation, we should establish equal partnership, and
the cooperation should benefit to all parties. We will follow international
rules and fully protect the intellectual property rights. We are, and
will always be a responsible member of the international family.
At the age of global economy, I strongly believe that, the development
of modem life science, and biotechnology will bring us a brighter and
more prosperous future. A worldwide corporation will certainly help us
to realize our magnificent prospects.
|